Molecular Partners AG
MOLN
$3.88
-$0.07-1.77%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 11.82M | 10.24M | 10.41M | 12.98M | 13.26M |
| Gross Profit | -11.82M | -10.24M | -10.41M | -12.98M | -13.26M |
| SG&A Expenses | 5.00M | 5.61M | 4.50M | 4.84M | 4.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.82M | 15.85M | 14.91M | 17.82M | 17.96M |
| Operating Income | -16.82M | -15.85M | -14.91M | -17.82M | -17.96M |
| Income Before Tax | -16.45M | -15.83M | -14.80M | -24.73M | -18.66M |
| Income Tax Expenses | -- | 5.00K | -- | -- | -2.20K |
| Earnings from Continuing Operations | -16.45M | -15.83M | -14.80M | -24.73M | -18.66M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.45M | -15.83M | -14.80M | -24.73M | -18.66M |
| EBIT | -16.82M | -15.85M | -14.91M | -17.82M | -17.96M |
| EBITDA | -16.20M | -15.57M | -14.25M | -17.15M | -17.34M |
| EPS Basic | -0.44 | -0.42 | -0.40 | -0.66 | -0.51 |
| Normalized Basic EPS | -0.27 | -0.27 | -0.24 | -0.36 | -0.32 |
| EPS Diluted | -0.44 | -0.42 | -0.40 | -0.66 | -0.51 |
| Normalized Diluted EPS | -0.27 | -0.27 | -0.24 | -0.36 | -0.32 |
| Average Basic Shares Outstanding | 37.50M | 37.41M | 37.40M | 37.39M | 36.87M |
| Average Diluted Shares Outstanding | 37.50M | 37.41M | 37.40M | 37.39M | 36.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |